Citation: Ja. Sacristan et Jc. Gomez, Olanzapine versus other antipsychotics in the treatment of schizophrenia -Reply, J CLIN PSY, 62(10), 2001, pp. 828-829
Authors:
Abad, F
Calbo, F
Zapater, P
Rodriguez-Vilanova, F
Garcia-Perez, LE
Sacristan, JA
Citation: F. Abad et al., Comparative pharmacoeconomic study of vancomycin and teicoplanin in intensive care patients, INT J ANT A, 15(1), 2000, pp. 65-71
Authors:
Sacristan, JA
Gilaberte, I
Boto, B
Buesching, DP
Obenchain, RL
Demitrack, M
Sola, VP
Alvarez, E
Artigas, F
Citation: Ja. Sacristan et al., Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial, INT CLIN PS, 15(2), 2000, pp. 107-113
Authors:
Sacristan, JA
Kennedy-Martin, T
Rosell, R
Cardenal, F
Anton, A
Lomas, M
Alberola, V
Massuti, B
Carrato, A
Minshall, M
Citation: Ja. Sacristan et al., Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer, LUNG CANC, 28(2), 2000, pp. 97-107
Authors:
Gomez, JC
Sacristan, JA
Hernandez, J
Breier, A
Carrasco, PR
Saiz, CA
Carbonell, EF
Citation: Jc. Gomez et al., The safety of olanzapine compared with other antipsychotic drugs: Results of an observational prospective study in patients with schizophrenia (EFESOstudy), J CLIN PSY, 61(5), 2000, pp. 335-343
Authors:
Sacristan, JA
Gomez, JC
Montejo, AL
Vieta, E
Gregor, KJ
Citation: Ja. Sacristan et al., Doses of olanzapine, risperidone, and haloperidol used in clinical practice: Results of a prospective pharmacoepidemiologic study, CLIN THER, 22(5), 2000, pp. 583-599
Authors:
Hylan, TR
Meneades, L
Crown, WH
Sacristan, JA
Gilaberte, I
Montejo, AL
Citation: Tr. Hylan et al., SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study, J AFFECT D, 52(1-3), 1999, pp. 111-119
Authors:
Salvador-Carulla, L
Haro, JM
Cabases, J
Madoz, V
Sacristan, JA
Vazquez-Barquero, JL
Citation: L. Salvador-carulla et al., Service utilization and costs of first-onset schizophrenia in two widely differing health service areas in North-East Spain, ACT PSYC SC, 100(5), 1999, pp. 335-343
Citation: Ja. Sacristan et al., Evaluation of effectiveness by randomized assignment using data bases. Evidence based on medicine?, MED CLIN, 111(16), 1998, pp. 623-627